Literature DB >> 21076976

Relationships between C-reactive protein, white blood cell count, and insulin resistance in a Chinese population.

Yu Xu1, Zhiyun Zhao, Xiaoying Li, Yufang Bi, Min Xu, Guang Ning.   

Abstract

This study is to clarify whether C-reactive protein (CRP) and white blood cell (WBC) count influence insulin homeostasis to the same degree. Serum CRP and peripheral WBC were measured in 739 subjects with normal glucose regulation, 512 with impaired glucose regulation, and 502 newly diagnosed diabetic patients. Levels of insulin resistance (IR) were assessed using the index of homeostasis model (HOMA-IR). Serum CRP and WBC were significantly correlated with HOMA-IR and risk factors of IR. Relative risks of IR for each 1-SD increase of Ln (CRP) and Ln (WBC) were 1.28 (1.10-1.47) and 1.15 (1.01-1.31), respectively after adjustment for age, sex, obesity measurements, and other traditional risk factors. Additional adjustment for WBC slightly attenuated the association between CRP and IR [1.25 (1.08-1.45); P = 0.003] whereas adjustment for CRP substantially attenuated the association of WBC with IR toward null (P = 0.134). Moreover, individuals with both high levels of CRP and WBC were at higher risks of IR than those with high CRP or WBC alone. Both CRP and WBC were significantly associated with risks of IR. CRP might be a more effective biomarker in terms of the association with IR.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21076976     DOI: 10.1007/s12020-010-9425-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  25 in total

Review 1.  Adipocytes as regulators of energy balance and glucose homeostasis.

Authors:  Evan D Rosen; Bruce M Spiegelman
Journal:  Nature       Date:  2006-12-14       Impact factor: 49.962

2.  Circulating interleukin 6 levels, blood pressure, and insulin sensitivity in apparently healthy men and women.

Authors:  J M Fernandez-Real; M Vayreda; C Richart; C Gutierrez; M Broch; J Vendrell; W Ricart
Journal:  J Clin Endocrinol Metab       Date:  2001-03       Impact factor: 5.958

3.  Elevated C-reactive protein in Native Canadian children: an ominous early complication of childhood obesity.

Authors:  R Retnakaran; A J G Hanley; P W Connelly; S B Harris; B Zinman
Journal:  Diabetes Obes Metab       Date:  2006-09       Impact factor: 6.577

Review 4.  Inflammation, stress, and diabetes.

Authors:  Kathryn E Wellen; Gökhan S Hotamisligil
Journal:  J Clin Invest       Date:  2005-05       Impact factor: 14.808

5.  High white blood cell count is associated with a worsening of insulin sensitivity and predicts the development of type 2 diabetes.

Authors:  Barbora Vozarova; Christian Weyer; Robert S Lindsay; Richard E Pratley; Clifton Bogardus; P Antonio Tataranni
Journal:  Diabetes       Date:  2002-02       Impact factor: 9.461

6.  Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS).

Authors:  A Festa; R D'Agostino; G Howard; L Mykkänen; R P Tracy; S M Haffner
Journal:  Circulation       Date:  2000-07-04       Impact factor: 29.690

7.  Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study.

Authors:  J S Yudkin; I Juhan-Vague; E Hawe; S E Humphries; G di Minno; M Margaglione; E Tremoli; T Kooistra; P E Morange; P Lundman; V Mohamed-Ali; A Hamsten
Journal:  Metabolism       Date:  2004-07       Impact factor: 8.694

8.  Serum C-reactive protein (CRP) and microalbuminuria in relation to fasting and 2-h postload plasma glucose in a Chinese population.

Authors:  Xiao-Ying Li; Min Xu; Ji-Guang Wang; Xin-Jun Wang; Yun Huang; Qi Cheng; Hong-Er Huang; Rui Li; Jie Xiang; Jiao-Rong Tan; Meng Dai; Guang Ning
Journal:  Clin Endocrinol (Oxf)       Date:  2008-08-07       Impact factor: 3.478

9.  Retinol-binding protein 4 is associated with impaired glucose regulation and microalbuminuria in a Chinese population.

Authors:  M Xu; X Y Li; J G Wang; X J Wang; Y Huang; Q Cheng; H E Huang; R Li; J Xiang; J R Tan; M Dai; G Ning
Journal:  Diabetologia       Date:  2009-06-09       Impact factor: 10.122

10.  White blood cell count is associated with macro- and microvascular complications in chinese patients with type 2 diabetes.

Authors:  Peter C Tong; Ka-Fai Lee; Wing-Yee So; Margaret H Ng; Wing-Bun Chan; Matthew K Lo; Norman N Chan; Juliana C Chan
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

View more
  5 in total

1.  Comparison of high-sensitivity C-reactive protein and fetuin-A levels before and after treatment for subjects with subclinical hyperthyroidism.

Authors:  Oktay Bilgir; Ferda Bilgir; Tuba Topcuoglu; Mehmet Calan; Ozlem Calan
Journal:  Endocrine       Date:  2013-06-19       Impact factor: 3.633

2.  C-reactive protein concentration as a significant correlate for metabolic syndrome: a Chinese population-based study.

Authors:  Tsan Yang; Chi-Hong Chu; Po-Chien Hsieh; Chih-Hsung Hsu; Yu-Ching Chou; Shih-Hsien Yang; Chyi-Huey Bai; San-Lin You; Lee-Ching Hwang; Tieh-Chi Chung; Chien-An Sun
Journal:  Endocrine       Date:  2012-07-19       Impact factor: 3.633

3.  Hemoglobin concentration and incident metabolic syndrome: a population-based large-scale cohort study.

Authors:  Yoshitaka Hashimoto; Muhei Tanaka; Toshihiro Kimura; Noriyuki Kitagawa; Masahide Hamaguchi; Mai Asano; Masahiro Yamazaki; Yohei Oda; Hitoshi Toda; Naoto Nakamura; Michiaki Fukui
Journal:  Endocrine       Date:  2015-04-12       Impact factor: 3.633

4.  Neutrophil lymphocyte ratio (NLR): A well assessment tool of glycemic control in type 2 diabetic patients.

Authors:  Mazhar Hussain; Muhammad Zafar Majeed Babar; Lubna Akhtar; Muhammad Shahbaz Hussain
Journal:  Pak J Med Sci       Date:  2017 Nov-Dec       Impact factor: 1.088

5.  White cell count trajectory and type 2 diabetes in health management population: a retrospective cohort study.

Authors:  Tengfei Yang; Bo Zhao; Xuelai Guan; Dongmei Pei
Journal:  BMJ Open       Date:  2022-09-20       Impact factor: 3.006

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.